Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-25

Hey @NashaNasha

I do believe that some posters here do actually.
I can't recall just ATM which ones, one just recently mentioned cpap as well as a drop of cbd.
I am sure there is plenty of anecdotal evidence surrounding this point already too.

BUT as you know the "Business Strategy" of this BOD moving forward is "Super Chargers"

"There’s an increasing body of scientific literature that indicates that the best use of cannabinoids is to
combine them with existing pharmaceutical drugs to produce better patient outcomes by either improving
product safety, efficacy, or both. At Incannex, we are the first mover globally to formally develop
sophisticated cannabinoid combination drugs as a business strategy.

Upon proving synergy in our compounds in pre-clinical activities, we have been able to aggressively pursue
patent protection over our three preferred unique combination compounds before competitors have been
able to do so. This has opened significant economic potential over a broad range of indications.
https://stocknessmonster.com/announcements/ihl.asx-3A585627/

Combine our unique business strategy based on "super charged' solutions for unmet needs and an economic
moat with our IP strategy, the potential is LIMITLESS. I agree exciting times are ahead.

Good luck @NashaNasha